RESULTS OF AN ANONYMOUS SURVEY OF PHARMACY EMPLOYEES AND DOCTORS REGARDING THE PROVISION OF PHARMACEUTICAL AID TO PATIENTS WITH ANXIETY, STRESS AND POST-TRAUMATIC STRESS DISORDER
DOI:
https://doi.org/10.11603/2312-0967.2025.1.15097Keywords:
stress, anxiety, post-traumatic stress disorder, antidepressants, questionnaireAbstract
The aim of the work - the analysis of the state of pharmaceutical and medical (in terms of treatment) assistance to patients with stress, anxiety, PTSD based on the results of an anonymous questionnaire of pharmaceutical and medical workers; as well as studying the issues of availability of drugs for the treatment of stress, anxiety, PTSD.
Materials: 300 questionnaires of pharmacy employees and 60 - of doctors. Methods: questionnaires, comparative analysis.
Results and Discussion. During 2022-2024, an anonymous survey of 300 pharmacy employees and 60 doctors was conducted to study the real state of pharmaceutical and medical (in terms of pharmacotherapy) assistance to patients with stress, anxiety, and PTSD that arise during war.
Most pharmacists chose the answers "very often" (56%±2.9) and "often" (37%±2.8) regarding the frequency of visits to pharmacies by visitors regarding stress and anxiety, and doctors confirmed that patients contact them daily (50%±6.5) or at least 1–3 times a week (42%±6.4) for the same reason.
Among the groups of drugs that are mainly prescribed by doctors / dispensed by pharmacists for people with stress, anxiety, PTSD, antidepressants (97%±2.2 / 97%±1), tranquilizers (87%±4.3 / 84%±2.1), hypnotics and sedatives (70%±5.9 / 85%±2) were the most common. A significant increase in the frequency of prescribing antidepressants with the beginning of the full-scale invasion was confirmed by 92%±3.5 doctors and the dispensing of these drugs from pharmacies by them was confirmed by 77%±2.43 pharmacists. Analysis of the responses of pharmaceutical workers revealed that most of them (60%±2.8) believe that visitors prefer drugs for the treatment of stress, anxiety disorders, and PTSD in the price range of 100–300 UAH per package.
At the same time, antidepressants from the group N06AB "Selective serotonin reuptake inhibitors", which led the responses of physician respondents for pharmacotherapy of patients with PTSD, have been included in the List of Reimbursable Drugs since September 2024.
Conclusions. The results of the questionnaire confirmed the importance of maintaining and improving the connection in the chain patient - doctor - pharmacist for providing pharmaceutical care to patients with stress, anxiety, PTSD.
References
Zaliska O, Oleshchuk O, Forman R, Mossialos E. Health impacts of the Russian invasion in Ukraine: need for global health action. The Lancet, 2022;399(10334):1450–2. DOI: 10.1016/s0140-6736(22)00615-8 DOI: https://doi.org/10.1016/S0140-6736(22)00615-8
Lukomska S. Osoblyvosti psykholohichnykh travm rosiisko-ukrainskoi viinyu konteksti yevrointehratsiinykh protsesiv. Visnyk Lvivskoho universytetu. Seriia psykholohichni nauky. 2022;Spetsvypusk:78-85. DOI: https://doi.org/10.30970/PS.2022.spec.11 DOI: https://doi.org/10.30970/PS.2022.spec.11
Ofitsiinyi sait Natsionalnoi sluzhby zdorovia Ukrainy. [Internet]. [cited 2025 January 10]. Available from: https://nszu.gov.ua/novini/v-esoz-protyagom-ostannih-dvoh-rokiv-fiksuyetsya-znachne-zbi-1203
Ofitsiinyi sait. World Health Organization. [Internet]. [cited 2025 January 10]. Available from: https://www.who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder
Ofitsiinyi sait. U.S.Food&Drug administration. [Internet]. [cited 2025 January 10]. Available from: https://www.fda.gov/drugs/news-events-human-drugs/advancing-treatments-post-traumatic-stress-disorder-ptsd-09062024
Scars on Their Souls: PTSD and Ukrainian Veterans. GLOBSEC Kyiv Office. [Internet]. [cited 2025 January 10]. Available from: file:///C:/Users/Tester/Downloads/%D0%A8%D0%A0%D0%90%D0%9C%D0%98%20%D0%9D%D0%90%20%D0%87%D0%A5%D0%9D%D0%86%D0%A5_0.pdf
Martyniuk IA. Psykholohichna travma ta posttravma: sutnist i sposoby podolannia. Naukovyi visnyk Natsionalnoho universytetu bioresursiv i pryrodokorystuvannia Ukrainy. 2015;230:276-82. Ukrainian.
Beres L. The Narrative Practitioner. London: Palgrave Macmillan, 2014. 240 p.
Mishyiev BV, Mykhailov YeH, Hrynevych VIu, Omelianovych K. Rozlady psykhichnoi sfery vnaslidok boiovykh dii: navch. posib. V.D.:VSV «Medytsyna», 2023. 127. Ukrainian.
Iribarren J, Prolo P, Neago N, Chiappelli F. Post-traumatic stress disorder: evidence-based research for the third millennium. Evid Based Complement Alternat Med. 2005;2:503-12. DOI: 10.1093/ecam/neh127 DOI: https://doi.org/10.1093/ecam/neh127
Elektronnyi dokument «Hostra reaktsiia na stres. Posttravmatychnyi stresovyi rozlad», 2024, [Internet]. [cited 2025 January 10]. https://moz.gov.ua/storage/uploads/ec4ae01d-d0d3-4c0a-bf92-3cefbef633be/dn_1265_19072024_dod.pdf.
Nemchenko AS, Liadenko AV, Nemchenko OA, Lebed SO. Otsinka dostupnosti likarskykh zasobiv dlia vykorystannia z rozladamypsykhiky ta povedinky za rezultatamy opytuvannia likariv ta far-matsevtiv v Ukraini. ScienceRise: Farmatsevtychna nauka. 2023;3(43):16-22. DOI: https://doi.org/10.15587/2519-4852.2023.281222 DOI: https://doi.org/10.15587/2519-4852.2023.281222
Ofitsiinyi sait Derzhavnoho reiestru likarskykh zasobiv Ukrainy. [Internet]. [cited 2025 January 10]. Available from: http://www.drlz.com.ua/.
Perelik likarskykh zasobiv, yaki pidliahaiut reimbursatsii za prohramoiu derzhavnykh harantii medychnoho obsluhovuvannia naselennia, stanom na 23 serpnia 2024 roku, nakaz Ministerstva okhorony zdorovia Ukrainy vid 04.09.2024 r. №1537. [Internet]. [cited 2025 January 10]. Available from: https://www.apteka.ua/reimbursement
Charles Hoge. Once a Warrior, Always a Warrior: Navigating the Transition from Combat to Home: Nash Format, 2024. 352.
Fediak I, Volosheniuk T. Marketing study of selective serotonin reuptake inhibitors for the treatment of post-traumatic stress disorder in military servants and war veterans. ScienceRise: Pharmaceutical Science. 2024;6(52):90–102. https://doi.org/10.15587/2519-4852.2024.308684 DOI: https://doi.org/10.15587/2519-4852.2024.308684
Bilousova NA. Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice. Current issues in pharmacy and medicine: science and practice. 2024;17(3):282-90. DOI: https://doi.org/10.14739/2409-2932.2024.3.306171 DOI: https://doi.org/10.14739/2409-2932.2024.3.306171
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
